EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Morphine self-administration is inhibited by the antioxidant N‐acetylcysteine and the anti-inflammatory ibudilast; an effect enhanced by their co-administration

María Elena Quintanilla, Paola Morales, Daniela Santapau, Javiera Gallardo, Rocío Rebolledo, Gabriel Riveras, Tirso Acuña, Mario Herrera-Marschitz, Yedy Israel, Fernando Ezquer iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0312828 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von María Elena Quintanilla und 9 weiteren Autor:innen. Beteiligte Einrichtung: Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile. Hauptthemen laut MEDLINE: Acetylcysteine, Antioxidants, Rats, Wistar, Morphine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Nacional de Investigación y Desarrollo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The treatment of opioid addiction mainly involves the medical administration of methadone or other opioids, aimed at gradually reducing dependence and, consequently, the need for illicit opioid procurement. Thus, initiating opioid maintenance therapy with a lower level of dependence would be advantageous. There is compelling evidence indicating that opioids induce brain oxidative stress and associated glial activation, resulting in the dysregulation of glutamatergic homeostasis, which perpetuates drug intake. The present study aimed to determine whether inhibiting oxidative stress and/or neuroinflammation reduces morphine self-administration in an animal model of opioid dependence.

Methods

Morphine dependence, assessed as voluntary morphine self-administration, was evaluated in Wistar-derived UChB rats. Following an extended period of morphine self-administration, animals were administered either the antioxidant N-acetylcysteine (NAC; 40 mg/kg/day), the anti-inflammatory ibudilast (7.5 mg/kg/day) or the combination of both agents. Oxidative stress and neuroinflammation were evaluated in the hippocampus, a region involved in drug recall that feeds into the nucleus accumbens, where the levels of the glutamate transporters GLT-1 and xCT were further assessed.

Results

Daily administration of either NAC or ibudilast led to a mild reduction in voluntary morphine intake, while the co-administration of both therapeutic agents resulted in a marked inhibition (-57%) of morphine self-administration. The administration of NAC or ibudilast markedly reduced both the oxidative stress induced by chronic morphine intake and the activation of microglia and astrocytes in the hippocampus. However, only the combined administration of NAC + ibudilast was able to restore the normal levels of the glutamate transporter GLT-1 in the nucleus accumbens.

Conclusion

Separate or joint administration of an antioxidant and anti-inflammatory agent reduced voluntary opioid intake, which could have translational value for the treatment of opioid use disorders, particularly in settings where the continued maintenance of oral opioids is a therapeutic option.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetylcysteineAntioxidantsRats, WistarMorphineOxidative StressPyridinesSelf AdministrationAnti-Inflammatory AgentsAnimalsRatsMaleMorphine DependenceExcitatory Amino Acid Transporter 2HippocampusNucleus AccumbensIndolizinesPyrazoles

Substanzen

AcetylcysteineibudilastAntioxidantsMorphinePyridinesAnti-Inflammatory AgentsExcitatory Amino Acid Transporter 2IndolizinesPyrazoles

Autor:innen und Institutionen

  • Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
  • Specialized Center for the Prevention of Substance use and the Treatment of Addictions (CESA), Faculty of Medicine, University of Chile, Santiago, Chile.
  • Department of Neuroscience, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
  • Center for Regenerative Medicine, Faculty of Medicine Clínica Alemana-Universidad del Desarrollo, Santiago, Chile.
  • Research Center for the Development of Novel Therapeutics Alternatives for Alcohol Use Disorders, Santiago, Chile.

ORCID-Profile: Fernando Ezquer

Förderung

  • Agencia Nacional de Investigación y Desarrollo

Zitieren

APA

Quintanilla, M. E., Morales, P., Santapau, D., Gallardo, J., Rebolledo, R., Riveras, G., Acuña, T., Herrera-Marschitz, M., Israel, Y., & Ezquer, F. (2024). Morphine self-administration is inhibited by the antioxidant N‐acetylcysteine and the anti-inflammatory ibudilast; an effect enhanced by their co-administration. PLOS ONE. https://doi.org/10.1371/journal.pone.0312828

Vancouver

Quintanilla ME, Morales P, Santapau D, Gallardo J, Rebolledo R, Riveras G, et al. Morphine self-administration is inhibited by the antioxidant N‐acetylcysteine and the anti-inflammatory ibudilast; an effect enhanced by their co-administration. PLOS ONE. 2024. doi:10.1371/journal.pone.0312828

BibTeX
@article{Quintanilla2024,
  author = {Quintanilla, María Elena and Morales, Paola and Santapau, Daniela and Gallardo, Javiera and Rebolledo, Rocío and Riveras, Gabriel and Acuña, Tirso and Herrera-Marschitz, Mario and Israel, Yedy and Ezquer, Fernando},
  title = {Morphine self-administration is inhibited by the antioxidant N‐acetylcysteine and the anti-inflammatory ibudilast; an effect enhanced by their co-administration},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0312828}
}
Kostenlos starten →